The Faculty Disclosure Policy of the Albert Einstein College of Medicine requires that faculty participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company, which might pose a potential, apparent, or real conflict of interest with regard to the contribution of the activity, and any discussions of unlabeled or investigational use of any commercial product, or device not yet approved in the United States must be disclosed.
Howard Kaufman, MD, FACS is a consultant with Therion Biologics Corporation and has received grant/research and other financial or material support from NIH, Doris Duke Foundation, Chiron Corporation, and Aventis Pasteur.
Michael R. Bishop, MD, FACP reports no conflict.
Mary L. Disis, MD, MS reports no conflict.
Michael A. Morse, MD is a consultant and/or speaker with Immunex and Searle, and has received grant/research support from Immunex, Corixa, and Vical.
Jeffrey Weber, MD, PhD is a consultant for Antigenics and has received grant/research support from CTL, Immunotherapeutics, Chiron, Schering, Immunex, Ilex, Bayer, and Genetics Institute.
Albert Einstein College of Medicine designates this continuing medical education activity for a maximum of 4 hours in Category 1 Credit towards the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.